FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2016

POSSESSION USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
SURGICAL ONCOLOGY
PAPER III
SURG.ONCO/J/16/47/III
Time 3 hours
Max. Marks 100
Important instructions:
• Attempt all questions in order.
• Each question carries 10 marks.
• Read the question carefully and answer to the point neatly and legibly.
• Do not leave any blank pages between two answers.
• Indicate the question number correctly for the answer in the margin space.
• Answer all the parts of a single question together.
• Start the answer to a question on a fresh page or leave adequate space between two answers.
• Draw table/diagrams/flowcharts wherever appropriate.
Write short notes on:
1. Peritoneal surface malignancies:
Give examples and current concepts of pathophysiology and
mechanism of spread.
Recent advances in its management.
5+5
2. Sentinel lymph node biopsy
Histopathology protocol and molecular diagnostic methods.
Non-radioisotope based SLNB techniques.
Role of SLNB in penile cancer management

3. Rationale and types of Intra-operative radiotherapy (IORT).
Role of IORT in breast cancer management.
5+5
4. Cancer prevention:
Risk reducing surgery.
Lifestyle factors
5+5
5. Genetic counseling for cancer:
Rationale and components of genetic counseling.
Treatment options for BRCA1 positive daughters of a familial
breast cancer patient.
5+5
6. Recent advances in breast cancer imaging:
Tomosynthesis.
Elastography.
Pros cons of MRI breast.

7. Immunotherapy for cancer:
Dendritic cell therapy.
Immunotherapy for melanoma.
Radio-immunoguided surgery.

P.T.O.
FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2016

POSSESSION USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE
EXAMINATION HALL.
SURGICAL ONCOLOGY
PAPER III
8. Energy sources in Surgical Oncology:
Ultrasonic energy
Cryotherapy
Radio-frequency ablation

9. Recent advances in Radiation-oncology:
Proton Beam therapy
TARGIT trial
Intensity Modulated Radiotherapy (IMRT).

10. Hormonal therapy for breast cancer:
Ovarian suppression
Aromatase inhibitors
5+5